5-16668294-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012334.3(MYO10):āc.6058C>Gā(p.Leu2020Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 1,612,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012334.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000166 AC: 41AN: 247256Hom.: 0 AF XY: 0.000134 AC XY: 18AN XY: 134098
GnomAD4 exome AF: 0.000373 AC: 544AN: 1460224Hom.: 0 Cov.: 31 AF XY: 0.000362 AC XY: 263AN XY: 726348
GnomAD4 genome AF: 0.000145 AC: 22AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.6058C>G (p.L2020V) alteration is located in exon 40 (coding exon 40) of the MYO10 gene. This alteration results from a C to G substitution at nucleotide position 6058, causing the leucine (L) at amino acid position 2020 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at